Spire Healthcare Group

Spire Healthcare said the deadline for a binding takeover offer from Toscafund has been extended to 21 August 2026. Toscafund has submitted a revised, non-binding offer of 250 pence per share in cash with an option for unlisted rollover shares and has largely completed its due diligence. The extension is intended to enable completion of the financing arrangements; a binding offer remains subject to usual conditions and is not certain. » Plus sur de.investing.com

Spire Healthcare said Sir Ian Cheshire will resign as chair on 30 September 2026. Debbie White, an independent non‑executive director since February 2023 and senior independent director since May 2023, will take on the role of designated chair with immediate effect and will assume the chair after Cheshire’s resignation. Sir Ian will be available in an advisory capacity during his six‑month notice period; Natalie Ceeney will take on the role of senior independent director. » Plus sur de.investing.com

Spire Healthcare’s shares rose slightly after the third extension of the binding deadline for a formal takeover offer from Toscafund to 6 August 2026. Toscafund holds 18% and in May made a non-binding offer of 250p per share (valuation around £1bn), which the board said it would recommend accepting if made formal. The recent sale of a portfolio of 12 Spire acute hospitals to Blue Owl and Moor Park for around £1.3bn supports the property value of the business and underpins the investment case behind the offer. Despite a difficult market environment, M&A dynamics and the offer trading above the share price continue to drive the stock’s performance. » Plus sur de.investing.com